Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/CELLTRION-INC-40742914/nieuws/Celltrion-presenteert-nieuwe-tweejarige-gegevens-voor-subcutane-injectiximab-CT-P13-SC-bij-inflamm-46021013/?utm_source=whatsapp&utm_medium=social&utm_campaign=share